Naritas Finance

..



.

ACN Business

Jacobson Pharma Updates on TAILORx Study

  • Written by ACN Newswire
Jacobson Pharma Updates on TAILORx Study
HONG KONG, June 13, 2018 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests, is pleased to share that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score results of 11 to 25. The long-awaited results of the TAILORx study, the largest ever breast cancer treatment trial, sponsored by the National Cancer Institute (NCI), and led by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN), provided definitive evidence that the Oncotype DX Breast Recurrence Score test identified 70 per cent of early-stage breast cancer patients who received no benefit from chemotherapy, and can be effectively treated with endocrine therapy alone. Additionally, the trial established that chemotherapy may provide life-saving benefit to 30 per cent of patients.

The TAILORx results were published on June 3rd in The New England Journal of Medicine in conjunction with a presentation during the Plenary Session at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, United States.

The Oncotype DX gene expression tests carried out by Genomic Health have been used to guide treatment decisions for more than 900,000 cancer patients in more than 90 countries. The Oncotype DX tests have redefined personalized medicine by making genomics a critical part of cancer diagnosis and treatment.

Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, said, "Breast cancer is one of the most common types of cancerous disease with about 4,000 new cases found in Hong Kong, as well as about 270,000 new cases in China. . Jacobson has been the exclusive distributor of Genomic Health in Hong Kong and Macau for 10 years. We are confident that with our close collaboration with Genomic Health and our in-depth experiences in the relevant markets, we are well positioned to continue expanding business opportunities emerging in this arena."

About Jacobson Pharma Corporation Limited (Stock Code: 2633)Jacobson Pharma is the largest generic drug company in Hong Kong with over 30% share of the total generic drug market for each year since 2012. The Group's proprietary medicines, notably being Po Chai Pills, Tong Tai Chung Woodlok Oil, Ho Chai Kung Tji Thung San, Contractubex Scar Gel Doan's Ointment, Flying Eagle Wood Lok Medicated Oil, Saplingtan, Shiling Oil and Col-gan Tablet have been widely recognized by the market. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com[1]

For media enquiries, please contact:Strategic Financial Relations LimitedVicky Lee Tel: (852) 2864 4834 Email: [email protected]Stephanie Liu Tel: (852) 2864 4852 Email: [email protected]Queenie Chan Tel: (852) 2864 4851 Email: [email protected]Fax: (852) 2527 1196[2][3][4]

Topic: Press release summarySectors: Daily Finance, HealthCare[5][6] http://www.acnnewswire.com From the Asia Corporate News Network

Copyright © 2018 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

References

  1. ^ http://www.jacobsonpharma.com (www.jacobsonpharma.com)
  2. ^ [email protected] (www.acnnewswire.com)
  3. ^ [email protected] (www.acnnewswire.com)
  4. ^ [email protected] (www.acnnewswire.com)
  5. ^ Daily Finance (www.acnnewswire.com)
  6. ^ HealthCare (www.acnnewswire.com)

Read more http://www.acnnewswire.com/press-release/english/44100/

Business Daily Media Business Reports

Di Jones real estate recognises high achievers

Di Jones celebrated its outstanding performers on Saturday (24 February 2018) evening at the Di Jones Real Estate Annual Awards.                               The bla...

Helen Hull - avatar Helen Hull

Eclipse Travel Expands Operations to New Zealand

Eclipse Travel, specialists in key adventure destinations such as Antarctica, the Arctic, Africa and Latin America, have announced today their expansion of operations to ...

Yvonne Kong - avatar Yvonne Kong

How medical professionals can benefit from an overall wealth management solution

As a health care professional, you have made it your life's work to focus on the care and health of the general public. While this kind of work can be extremely rewarding...

News Feature Team - avatar News Feature Team

Why Pinterest Should Be Part of Your Marketing Strategy

Pinterest is a growing social media platform that can deliver significant traffic to your website and new followers to your brand. With it’s steady growth and outrageous ...

Greg Nunan - avatar Greg Nunan

The top reasons why gyms fail

Steve Grant is a Business Coach and Founder of GymHub.com.au   Every month thousands of new trainers walk out of their 6-month course with the qualifications needed ...

Steve Grant - avatar Steve Grant

WHITE LABEL NOBA’s Winter 2016 season: Earth + Country

Taking cues from the warm winter colours of tobacco and caramel, and combining them with the strength of navy and the embracing lightness of whites and creams; and then...

Kath Rose - avatar Kath Rose

Former Etihad boss brings substantial event insight to PMY Group Board

Paul Sergeant PMY Group, the architects of the digital insurgency occurring at major venues across Australia and New Zealand, are delighted to welcome 35 year even...

Annie Konieczny - avatar Annie Konieczny

More training for coffee making than property sales: REINSW

Sydney 9 May 2016. An overhaul of education and training standards for the real estate profession must take place to help prevent illegal activities, according to the Rea...

Helen Hull - avatar Helen Hull